Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Evoskin is a topical supportive care agent developed by Laboratoires Evaux, specifically formulated for the management of skin toxicities associated with cancer treatments, such as radiation dermatitis. The product is based on thermal spring water from Evaux-les-Bains, which is naturally rich in trace elements including silicon, lithium, and manganese. These minerals are known for their soothing, anti-inflammatory, and skin-repairing properties. Evoskin works by providing a protective barrier, intensely hydrating the skin, and reinforcing the cutaneous barrier to mitigate the damage caused by ionizing radiation. It is frequently used in oncological dermatology to improve patient quality of life and ensure treatment continuity in patients undergoing radiotherapy for conditions like breast cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Evoskin.